Lv1
50 积分 2025-03-08 加入
Pharmacokinetic Studies of a Novel c‐Met Targeting PROTAC Drug Candidate Using UPLC‐MS/MS Quantification Methods
6个月前
已完结
Precision Ferroptosis Amplification via SLC7A11‐Directed Proteasomal Degradation for Enhanced Cancer Therapy
7个月前
已完结
Liposomal STAT3-Degrading PROTAC Prodrugs Promote Anti-Hepatocellular Carcinoma Immunity via Chemically Reprogramming Cancer Stem Cells
8个月前
已完结
Dual-Action-Only PROTACs
1年前
已完结
Discovery of a Proteolysis-Targeting Chimera Degrader of JAK2 as a Potential Therapeutic Agent for JAK2-Mediated Myeloproliferative Neoplasms
1年前
已完结
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization toward orally available bifunctional protein degraders
1年前
已完结